Triochem Products Intrinsic Value
Triochem Products (TRIPR) median intrinsic value is ₹52.17 from 3 valuation models (range ₹52–₹52), vs current price ₹17.39 — +200.0% upside (Trading Below Calculated Value), margin of safety 66.7%. Read Triochem Products dividend policy for the complete payout history and dividend yield track record.
TRIPR Valuation Methods Summary — DCF, Graham Number & P/E
Triochem Products intrinsic value across 3 models vs current price ₹17.39 — upside/downside and value range per method. Analyse Triochem Products shareholding analysis to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹52.17 | ₹41.74 - ₹62.60 | +200.0% | EPS: ₹325.34, Sector P/E: 22x |
| PEG Ratio Method | growth | ₹52.17 | ₹46.95 - ₹57.39 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹52.17 | ₹46.95 - ₹57.39 | +200.0% | Revenue Growth: -30.0%, Adj P/E: 12.8x |
TRIPR Intrinsic Value vs Market Price — All Valuation Models
Triochem Products fair value range ₹52–₹52 vs current market price ₹17.39 across 3 valuation models. For current market price and key ratios, visit TRIPR screener.
TRIPR Intrinsic Value Analysis — Undervalued or Overvalued?
Triochem Products median intrinsic value ₹52.17, current price ₹17.39 — Trading Below Calculated Value by 200.0%, margin of safety 66.7%.
What is the intrinsic value of TRIPR?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Triochem Products (TRIPR) is ₹52.17 (median value). With the current market price of ₹17.39, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹52.17 to ₹52.17, indicating ₹52.17 - ₹52.17.
Is TRIPR undervalued or overvalued?
Based on our multi-method analysis, Triochem Products (TRIPR) appears to be trading below calculated value by approximately 200.0%.
TRIPR Financial Health — Key Ratios vs Industry Benchmarks
Triochem Products financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 38.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
TRIPR Cash Flow Quality — Operating & Free Cash Flow
Triochem Products operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹10 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |